GHODGE-DISSERTATION-2015.Pdf (5.049Mb)
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
WO 2018/064165 A2 (.Pdf)
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2018/064165 A2 05 April 2018 (05.04.2018) W !P O PCT (51) International Patent Classification: Published: A61K 35/74 (20 15.0 1) C12N 1/21 (2006 .01) — without international search report and to be republished (21) International Application Number: upon receipt of that report (Rule 48.2(g)) PCT/US2017/053717 — with sequence listing part of description (Rule 5.2(a)) (22) International Filing Date: 27 September 2017 (27.09.2017) (25) Filing Language: English (26) Publication Langi English (30) Priority Data: 62/400,372 27 September 2016 (27.09.2016) US 62/508,885 19 May 2017 (19.05.2017) US 62/557,566 12 September 2017 (12.09.2017) US (71) Applicant: BOARD OF REGENTS, THE UNIVERSI¬ TY OF TEXAS SYSTEM [US/US]; 210 West 7th St., Austin, TX 78701 (US). (72) Inventors: WARGO, Jennifer; 1814 Bissonnet St., Hous ton, TX 77005 (US). GOPALAKRISHNAN, Vanch- eswaran; 7900 Cambridge, Apt. 10-lb, Houston, TX 77054 (US). (74) Agent: BYRD, Marshall, P.; Parker Highlander PLLC, 1120 S. Capital Of Texas Highway, Bldg. One, Suite 200, Austin, TX 78746 (US). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. -
Ribonuclease E Organizes the Protein Interactions in the Escherichia Coli RNA Degradosome
Downloaded from genesdev.cshlp.org on September 26, 2021 - Published by Cold Spring Harbor Laboratory Press Ribonuclease E organizes the protein interactions in the Escherichia coli RNA degradosome Nathalie F. Vanzo,1 Yeun Shan Li,2 Be´atrice Py,2,3 Erwin Blum,2 Christopher F. Higgins,2,4 Lelia C. Raynal,1 Henry M. Krisch,1 and Agamemnon J. Carpousis1,5 1Laboratoire de Microbiologie et Ge´ne´tique Mole´culaire, UPR 9007, Centre National de la Recherche Scientifique (CNRS), 31062 Toulouse Cedex, France; 2Nuffield Department of Clinical Biochemistry and Imperial Cancer Research Fund Laboratories, Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DS, UK The Escherichia coli RNA degradosome is the prototype of a recently discovered family of multiprotein machines involved in the processing and degradation of RNA. The interactions between the various protein components of the RNA degradosome were investigated by Far Western blotting, the yeast two-hybrid assay, and coimmunopurification experiments. Our results demonstrate that the carboxy-terminal half (CTH) of ribonuclease E (RNase E) contains the binding sites for the three other major degradosomal components, the DEAD-box RNA helicase RhlB, enolase, and polynucleotide phosphorylase (PNPase). The CTH of RNase E acts as the scaffold of the complex upon which the other degradosomal components are assembled. Regions for oligomerization were detected in the amino-terminal and central regions of RNase E. Furthermore, polypeptides derived from the highly charged region of RNase E, containing the RhlB binding site, stimulate RhlB activity at least 15-fold, saturating at one polypeptide per RhlB molecule. A model for the regulation of the RhlB RNA helicase activity is presented. -
The Structure and Function of the Gram-Positive Bacterial RNA Degradosome
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Frontiers - Publisher Connector REVIEW published: 03 February 2017 doi: 10.3389/fmicb.2017.00154 The Structure and Function of the Gram-Positive Bacterial RNA Degradosome Kyu Hong Cho* Department of Biology, Indiana State University, Terre Haute, IN, USA The RNA degradosome is a highly structured protein complex responsible for bulk RNA decay in bacteria. The main components of the complex, ribonucleases, an RNA helicase, and glycolytic enzymes are well-conserved in bacteria. Some components of the degradosome are essential for growth and the disruption of degradosome formation causes slower growth, indicating that this complex is required for proper cellular function. The study of the Escherichia coli degradosome has been performed extensively for the last several decades and has revealed detailed information on its structure and function. On the contrary, the Gram-positive bacterial degradosome, which contains ribonucleases different from the E. coli one, has been studied only recently. Studies on the Gram-positive degradosome revealed that its major component RNase Y was necessary for the full virulence of medically important Gram-positive bacterial pathogens, Edited by: suggesting that it could be a target of antimicrobial therapy. This review describes the Marc Bramkamp, Ludwig Maximilian University of structures and function of Gram-positive bacterial RNA degradosomes, especially those Munich, Germany of a Gram-positive model organism Bacillus subtilis, and two important Gram-positive Reviewed by: pathogens, Staphylococcus aureus and Streptococcus pyogenes. Jörg Stülke, University of Göttingen, Germany Keywords: Gram-positive RNA degradosome, B. subtilis, S. -
Lecture 1 Enzymes in Genetic Engineering: Restriction Nucleases
NPTEL – Bio Technology – Genetic Engineering & Applications MODULE 2: LECTURE 1 ENZYMES IN GENETIC ENGINEERING: RESTRICTION NUCLEASES: EXO & ENDO NUCLEASES 2-1.1 Introduction: A restriction enzyme is a nuclease enzyme that cleaves DNA sequence at a random or specific recognition sites known as restriction sites. In bacteria, restriction enzymes form a combined system (restriction + modification system) with modification enzymes that methylate the bacterial DNA. Methylation of bacterial DNA at the recognition sequence typically protects the own DNA of the bacteria from being cleaved by restriction enzyme. There are two different kinds of restriction enzymes: (1) Exonucleases catalyses hydrolysis of terminal nucleotides from the end of DNA or RNA molecule either 5’to 3’ direction or 3’ to 5’ direction. Example: exonuclease I, exonuclease II etc. (2) Endonucleases can recognize specific base sequence (restriction site) within DNA or RNA molecule and cleave internal phosphodiester bonds within a DNA molecule. Example: EcoRI, Hind III, BamHI etc. 2-1.2History: In 1970 the first restriction endonuclease enzyme HindII was isolated. For the subsequent discovery and characterization of numerous restriction endonucleases, in 1978 Daniel Nathans, Werner Arber, and Hamilton O. Smith awarded for Nobel Prize for Physiology or Medicine. Since then, restriction enzymes have been used as an essential tool in recombinant DNA technology. Joint initiative of IITs and IISc – Funded by MHRD Page 1 of 30 NPTEL – Bio Technology – Genetic Engineering & Applications 2-1.3 Restriction Endonuclease Nomenclature: Restriction endonucleases are named according to the organism in which they were discovered, using a system of letters and numbers. For example, HindIII (pronounced “hindee-three”) was discovered in Haemophilus influenza (strain d). -
Evidence for a Degradosome-Like Complex in the Mitochondria of Trypanosoma Brucei
FEBS Letters 583 (2009) 2333–2338 journal homepage: www.FEBSLetters.org Evidence for a degradosome-like complex in the mitochondria of Trypanosoma brucei Jonelle L. Mattiacio 1, Laurie K. Read * Depatment of Microbiology and Immunology, Witebsky Center for Microbial Pathogenesis and Immunology, SUNY Buffalo School of Medicine, Buffalo, NY 14214, USA article info abstract Article history: Mitochondrial RNA turnover in yeast involves the degradosome, composed of DSS-1 exoribonuc- Received 29 May 2009 lease and SUV3 RNA helicase. Here, we describe a degradosome-like complex, containing SUV3 Accepted 11 June 2009 and DSS-1 homologues, in the early branching protozoan, Trypanosoma brucei. TbSUV3 is mitoc- Available online 18 June 2009 hondrially localized and co-sediments with TbDSS-1 on glycerol gradients. Co-immunoprecipitation demonstrates that TbSUV3 and TbDSS-1 associate in a stable complex, which differs from the yeast Edited by Michael Ibba degradosome in that it is not stably associated with mitochondrial ribosomes. This is the first report of a mitochondrial degradosome-like complex outside of yeast. Our data indicate an early evolution- Keywords: ary origin for the mitochondrial SUV3/DSS-1 containing complex. RNA turnover RNA processing Trypanosome Structured summary: RNA helicase MINT-7187980: SUV3 (genbank_protein_gi:XP_844349) and DSS1 (uniprotkb:Q38EM3) colocalize Exoribonuclease (MI:0403) by cosedimentation (MI:0027) MINT-7188074: SUV3 (genbank_protein_gi:XP_844349) physically interacts (MI:0914) with DSS1 (uni- protkb:Q38EM3) by anti tag co-immunoprecipitation (MI:0007) Ó 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved. 1. Introduction only known exoribonuclease involved in yeast mitochondrial RNA (mtRNA) turnover [8]. -
Et Al., 2015; Mandell and Green, 2011)
Analysis of the Gut Microbiota of Japanese Alzheimer’s Disease Patients and Characterization of Their Butyrate-Producing Bacteria 2018, July NGUYEN THI THUY TIEN Graduate School of Environmental and Life Science (Doctor’s Course) OKAYAMA UNIVERSITY 0 I. GENERAL INTRODUCTION 1. Overview of Alzheimer’s disease a. Description/Definition Alzheimer’s disease (AD) is the most common type of age-related disease (aged over 65 years old), accounting for about 55 – 70% of dementia (Bertram, 2007; Bu et al., 2015; Mandell and Green, 2011). AD is characterized by progressive loss of memory and neurodegeneration of the central nervous system, leading to disorder in cognition and behavior of AD patients (Bertram, 2007; Mandell and Green, 2011). The life span of AD patients from onset may last about 10 years but can be as long as 20 years. b. Stages and symptoms of Alzheimer’s disease Stages of AD vary among individual and determination of stages that patients are suffering from is the most importance of AD treatment. The standard approach to classify AD stages relies on a mental status examination, the Mini-Mental State Examination (MMSE) (Folstein et al., 1975; Knopman). AD manifestations can be categorized into three stages with symptoms (López and DeKosky, 2008) presented in Table 1. 1 Table 1. MMSE scores and symptoms of each stage of AD (López and DeKosky, 2008) Stage by MMSE Cognitive Behavioral Neurological scores Mild Cognitive function is Apathy and heavy The neurological exam (score ≥ still in fairly good stresses may occur. cannot detect the changes. 20) condition. In this However, their mood is However, mild stage, IADL of still stable. -
WO 2014/135633 Al 12 September 2014 (12.09.2014) P O P C T
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization I International Bureau (10) International Publication Number (43) International Publication Date WO 2014/135633 Al 12 September 2014 (12.09.2014) P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every C12N 9/04 (2006.01) C12P 7/16 (2006.01) kind of national protection available): AE, AG, AL, AM, C12N 9/88 (2006.01) AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, (21) Number: International Application DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, PCT/EP2014/054334 HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, (22) International Filing Date: KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, 6 March 2014 (06.03.2014) MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (25) Filing Language: English SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, (26) Publication Language: English TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: 13 158012.8 6 March 2013 (06.03.2013) EP (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, (71) Applicants: CLARIANT PRODUKTE (DEUTSCH- GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, LAND) GMBH [DE/DE]; Briiningstrasse 50, 65929 UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, Frankfurt am Main (DE). -
RNA Degradosomes Exist in Vivo in Escherichia Coli As Multicomponent Complexes Associated with the Cytoplasmic Membrane Via the N-Terminal Region of Ribonuclease E
Corrections BIOCHEMISTRY. For the article ‘‘RNA degradosomes exist in vivo in Escherichia coli as multicomponent complexes associated with the cytoplasmic membrane via the N-terminal region of ribo- nuclease E’’ by Gunn-Guang Liou, Wann-Neng Jane, Stanley N. Cohen, Na-Sheng Lin, and Sue Lin-Chao, which appeared in number 1, January 2, 2001, of Proc. Natl. Acad. Sci. USA (98, 63–68; First Published December 26, 2000; 10.1073͞ pnas.011535498), the authors note that the y axis label of Fig. 1B ͞ should read ‘‘picomoles OD600.’’ The corresponding text in the Fig. 1 legend on page 64 and the results described on page 66, line 2 from the bottom of the left-hand column, should also be in units of picomole per OD600. www.pnas.org͞cgi͞doi͞10.1073͞pnas.161275298 NEUROBIOLOGY. For the article ‘‘In vivo induction of massive proliferation, directed migration, and differentiation of neural cells in the adult mammalian brain’’ by James Fallon, Steve Reid, Richard Kinyamu, Isaac Opole, Rebecca Opole, Janie Baratta, Murray Korc, Tiffany L. Endo, Alexander Duong, Gemi Nguyen, Masoud Karkehabadhi, Daniel Twardzik, and Sandra Loughlin, which appeared in number 26, December 19, 2000, of Proc. Natl. Acad. Sci. USA (97, 14686–14691), the authors note the follow- ing correction. Dr. Sanjiv Patel’s name and affiliation were omitted from the list of authors. Dr. Patel’s affiliation is St. Joseph’s Hospital and Medical Center, Paterson, NJ 07503. The corrected list of authors is: James Fallon, Steve Reid, Richard Kinyamu, Isaac Opole, Rebecca Opole, Janie Baratta, Murray Korc, Tiffany L. Endo, Alexander Duong, Gemi Nguyen, Ma- soud Karkehabadhi, Daniel Twardzik, Sanjiv Patel, and Sandra Loughlin. -
A Grad-Seq View of RNA and Protein Complexes in Pseudomonas
bioRxiv preprint doi: https://doi.org/10.1101/2020.12.06.403469; this version posted December 6, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 2 A Grad-seq view of RNA and protein complexes in Pseudomonas 3 aeruginosa under standard and bacteriophage predation conditions 4 5 Milan Gerovaca, Laura Wickea,b, Kotaro Chiharac, Cornelius Schneidera,d, 6 Rob Lavigneb,#, Jörg Vogela,c,# 7 8 a Institute for Molecular Infection Biology (IMIB), University of Würzburg, 9 97080 Würzburg, Germany 10 b Laboratory of Gene Technology, KU Leuven, 3001 Leuven, Belgium 11 c Helmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz Centre for 12 Infection Research (HZI), 97080 Würzburg, Germany 13 d Department of Biochemistry and Cancer Therapy Research Center (CTRC), 14 Theodor Boveri-Institute, University of Würzburg, 97074 Würzburg, Germany 15 16 # Corresponding authors: [email protected], [email protected] 17 18 Keywords: Grad-seq, Pseudomonas, ΦKZ, bacteriophage, infection 19 20 Running title: Grad-seq in Pseudomonas and phage 21 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.12.06.403469; this version posted December 6, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 22 ABSTRACT 23 The Gram-negative rod-shaped bacterium Pseudomonas aeruginosa is not only a major cause 24 of nosocomial infections but also serves as a model species of bacterial RNA biology. While 25 its transcriptome architecture and post-transcriptional regulation through the RNA-binding 26 proteins Hfq, RsmA and RsmN have been studied in detail, global information about stable 27 RNA–protein complexes is currently lacking in this human pathogen. -
Ribosomal RNA Degradation Induced by the Bacterial RNA Polymerase Inhibitor Rifampicin
Downloaded from rnajournal.cshlp.org on October 6, 2021 - Published by Cold Spring Harbor Laboratory Press Ribosomal RNA degradation induced by the bacterial RNA polymerase inhibitor rifampicin. Lina Hamouche1, Leonora Poljak1, and Agamemnon J. Carpousis1,2† 1LMGM, Université de Toulouse, CNRS, UPS, CBI, Toulouse, France 2TBI, Université de Toulouse, CNRS, INRAE, INSA, Toulouse, France Running title: Rifampicin-induced rRNA degradation †Corresponding author: [email protected] 1 Downloaded from rnajournal.cshlp.org on October 6, 2021 - Published by Cold Spring Harbor Laboratory Press Abstract Rifampicin, a broad-spectrum antibiotic, inhibits bacterial RNA polymerase. Here we show that rifampicin treatment of Escherichia coli results in a 50% decrease in cell size due to a terminal cell division. This decrease is a consequence of inhibition of transcription as evidenced by an isogenic rifampicin-resistant strain. There is also a 50% decrease in total RNA due mostly to a 90% decrease in 23S and 16S rRNA levels. Control experiments showed this decrease is not an artifact of our RNA purification protocol and therefore due to degradation in vivo. Since chromosome replication continues after rifampicin treatment, ribonucleotides from rRNA degradation could be recycled for DNA synthesis. Rifampicin- induced rRNA degradation occurs under different growth conditions and in different strain backgrounds. However, rRNA degradation is never complete thus permitting the re-initiation of growth after removal of rifampicin. The orderly shutdown of growth under conditions where the induction of stress genes is blocked by rifampicin is noteworthy. Inhibition of protein synthesis by chloramphenicol resulted in a partial decrease in 23S and 16S rRNA levels whereas kasugamycin treatment had no effect. -
Genome-Wide Investigation of Cellular Functions for Trna Nucleus
Genome-wide Investigation of Cellular Functions for tRNA Nucleus- Cytoplasm Trafficking in the Yeast Saccharomyces cerevisiae DISSERTATION Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University By Hui-Yi Chu Graduate Program in Molecular, Cellular and Developmental Biology The Ohio State University 2012 Dissertation Committee: Anita K. Hopper, Advisor Stephen Osmani Kurt Fredrick Jane Jackman Copyright by Hui-Yi Chu 2012 Abstract In eukaryotic cells tRNAs are transcribed in the nucleus and exported to the cytoplasm for their essential role in protein synthesis. This export event was thought to be unidirectional. Surprisingly, several lines of evidence showed that mature cytoplasmic tRNAs shuttle between nucleus and cytoplasm and their distribution is nutrient-dependent. This newly discovered tRNA retrograde process is conserved from yeast to vertebrates. Although how exactly the tRNA nuclear-cytoplasmic trafficking is regulated is still under investigation, previous studies identified several transporters involved in tRNA subcellular dynamics. At least three members of the β-importin family function in tRNA nuclear-cytoplasmic intracellular movement: (1) Los1 functions in both the tRNA primary export and re-export processes; (2) Mtr10, directly or indirectly, is responsible for the constitutive retrograde import of cytoplasmic tRNA to the nucleus; (3) Msn5 functions solely in the re-export process. In this thesis I focus on the physiological role(s) of the tRNA nuclear retrograde pathway. One possibility is that nuclear accumulation of cytoplasmic tRNA serves to modulate translation of particular transcripts. To test this hypothesis, I compared expression profiles from non-translating mRNAs and polyribosome-bound translating mRNAs collected from msn5Δ and mtr10Δ mutants and wild-type cells, in fed or acute amino acid starvation conditions. -
RNA Helicases in RNA Decay
Biochemical Society Transactions (2018) 46 163–172 https://doi.org/10.1042/BST20170052 Review Article RNA helicases in RNA decay Vanessa Khemici and Patrick Linder Department of Microbiology and Molecular Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland Correspondence: Patrick Linder ([email protected]) RNA molecules have the tendency to fold into complex structures or to associate with complementary RNAs that exoribonucleases have difficulties processing or degrading. Therefore, degradosomes in bacteria and organelles as well as exosomes in eukaryotes have teamed-up with RNA helicases. Whereas bacterial degradosomes are associated with RNA helicases from the DEAD-box family, the exosomes and mitochondrial degra- dosome use the help of Ski2-like and Suv3 RNA helicases. Introduction All living cells encounter situations where they need to adapt gene expression to changing environ- mental conditions. The synthesis of new mRNAs to be used for translation and the release of seques- tered or translational inactive mRNAs allow the cells to express new proteins. On the other hand, processing and degradation of RNAs not only helps to recycle essential components, but also to shut down expression of genes that are no longer required or would even be detrimental for living under a new condition. Moreover, remnants of processed or aberrant transcripts must rapidly be degraded to avoid the production of useless or even toxic peptides and proteins. Eubacteria, Archaea, and eukar- yotes have developed dedicated pathways and complexes to process RNA, check the accuracy of RNAs (surveillance), and feed undesired RNA into exoribonucleases that degrade RNA in a 30–50 or 50–30 direction.